Olanzapine-induced neutropenia: mechanism and treatment.
Duggal
Harpreet S
HS
Gates
Charlie
C
Pathak
Praveen C
PC
D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D001772:Blood Cell Count; D015283:Citalopram / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced*; D000077152:Olanzapine
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D015283:Citalopram; D001569:Benzodiazepines; D000077152:Olanzapine